Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2003

Open Access 01.12.2003 | Case report

Desmoid tumors of the abdominal wall: A case report

verfasst von: Marcus Overhaus, Pan Decker, Hans Peter Fischer, Hans Jochen Textor, Andreas Hirner

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2003

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Desmoid tumors are slow growing deep fibromatoses with aggressive infiltration of adjacent tissue but without any metastatic potential.

Case Presentation

We report on two female patients with desmoid tumor of the abdominal wall who underwent primary resection. Both patients had a history of an earlier abdominal surgery. Preoperative evaluation included abdominal ultrasound, magnetic resonance imaging and computed tomography. The histology in both cases revealed a desmoid tumor.

Conclusion

Complete surgical resection is the first line management of this tumor entity.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-1-11) contains supplementary material, which is available to authorized users.

Competing interests

None declared.

Authors' contributions

MO participated in the preparation of the manuscript, literature search and drafted the manuscript.
PD was responsible for the operations, follow-up of the patients and data preparation and conceived of the study.
HPF carried out the tissue preparation, (immuno)histology and edited the manuscript for its scientific content.
HJT accomplished and analysed the CT scans and MRT and approved the final version of the manuscript.
AH participated in its design and coordination.
All authors read and approved the final manuscript.
Abkürzungen
computed tomography scan (CT)
magnet-resonance-tomography (MRT), familial adenomatous polyposis (FAP)

Background

Desmoid tumors are benign myofibroblastic neoplasms originating from the muscle aponeurosis and classified as deep fibromatoses [1]. They constitute 3% of all soft tissue tumors and 0.03% of all neoplasms [2]. Despite their aggressive local infiltration, desmoid tumors lack a metastatic potential [3]. However, because of this local infiltration and compression of surrounding structures, a high recurrence rate exists and in anatomic locations with restricted access to surgical resection desmoid tumors can lead to death [4]. Especially in patients with familial adenomatous polyposis (FAP) undergoing colectomy desmoid tumors are the leading cause of morbidity and mortality [5].
Molecular studies demonstrated desmoid tumors in FAP as clonal neoplasms arising from germline mutation or changes in the APC alleles [68]. Cytogenic data verified clonal chromosome aberrations in deep-seated sporadic extra-abdominal fibromatoses and lesions of the abdominal wall and therefore provide additional evidence for the neoplastic nature of these lesions [9].
Main locations of desmoid tumor occurrence are the proximal extremities, the abdominal wall and the mesenteric intestine in patients with FAP [10]. In sporadic cases, they occur in localisations of trauma, and scars or irradiation. The therapeutic management of these tumors is still controversial.

Case Presentation

Case 1

A 28-year-old female recognized a left lower abdominal wall tumor. In her history she reported an appendectomy and two pregnancies with spontaneous birth in 1994 and 1999. On clinical admission, a painless tumor was investigated without any contact to hip bone structures. Analysed blood parameters were within normal range and tumor markers were negative.
Preoperative computed tomography scan (CT, figure 1) and magnet-resonance-tomography (MRT, figure 2) revealed a left lower abdominal wall tumor of unknown dignity. The MRT morphology demonstrated a fibrotic tumor, originating from the transversal and internal oblique abdominal muscle fascia. The resection of the tumor with excision of the oblique internal abdominal muscle followed and the defect was covered with a Bard Composix-Mesh® (C. R. Bard, Inc., 730 Central Aves Murray Hill, New Jersey, 07974, USA) and major omentum.
The postoperative course was uneventful and the patient was discharged at the 8th postoperative day.

Case 2

A 37-year-old female recognized an initially painless tumor in the right lower abdominal wall. In her history, the patient reported on a laparoscopic resection of an ovarian-cyst in 1993 and two pregnancies (1995 and 1997) with caesarean section. On admission, a palpable demarcated fixed tumor in the right lower third of the lateral abdominal wall was investigated. Analysed blood parameters were within normal range and tumor markers negative.
The CT revealed an ovarian-tumor, combined with a right abdominal wall tumor of unknown dignity. A metastasis of the ovarian-tumor, a lymphoma or a sarcoma was discussed as differential diagnosis. The MRT demonstrated the abdominal wall tumor originating from the abdominal transversal muscle and internal abdominal oblique muscle fascia. First, extirpation of the right ovary was performed. The resection of the abdominal wall tumor included the excision of the internal abdominal oblique muscle, replaced by a Bard Composix-Mesh® and covered with major omentum.
The postoperative course was uneventful and the patient was discharged at the 9th postoperative day.

Histological examination Case 1 and 2

Microscopic examination of the resected specimen in both the cases revealed the spindle-cellular tumors immigrated through muscle-tissues consisting of partially intact musclefibers surrounded by spindle like elements. Tumor-cells had a pale eosinophilic cytoplasm and chromatin structures and were embedded in collagen network interrupted by fibrotic sections (Figure 3). The immunohistochemistry revealed a minority of spindled tumor cells, expressing smooth muscle cell actin. Lower than 3% of the tumor-cells expressed the proliferative Ki 67 antigen. A desmoid tumor was diagnosed in both cases (figure 4).
Sections from the ovary in case 2 revealed a demarcated, non capsulated, spindle-cellular, collagen rich tumor a diagnosis of an ovarian fibroma without signs of malignancy was made.

Discussion

Desmoid tumors are benign deep fibromatoses, originating from fascia and muscle aponeurosis with an infiltrating growth [11]. They are primary located abdominally or intraabdominally [1], whereas only sporadic cases describe a localisation within the thorax wall [12] or retroperitoneally [13]. The desmoid tumor is often associated with female gender, FAP [14] and occasionally with surgical trauma [15]. It has a higher prevalence in women who experienced pregnancy [16]. Depending on the tumors size, on the therapy and on the negative resection margins, recurrence occurs in up to 45% [17].
CT scan localizes the tumor and excludes metastasis (figure 1). MRT reveals the tumor's hypointensity on T1 and demonstrates variable signal intensity on T2 weighted imaging, depending on the accumulation of mucoid structures (figure 2). Therefore, a differentiation from other solid tumors is impossible using morphological criteria [18]. Histology is the only evidentiary method which demonstrates long fascicles of spindle cells of variable cell-density with few mitoses and absence of atypical nucleus-separations (figure 3). Characteristically, there is a diffuse cell infiltration of adjacent tissue structures. Immunohistochemical response for actin can be partially positive and immunohistochemical muscle cell markers delimit desmoid tumors from fibrosarcoma [19].
The therapy of choice is still controversial [20]. Anti-inflammatory treatment [21], hormone-therapy [22] and chemotherapy [23] were not shown to be effective. These therapies are limited to patients, in whom resection is technically impossible because of a widespread tumor infiltration.
The effectiveness and indication of initial and adjuvant radiation is not proven yet. In a comparative analysis, a significantly better local recurrence control was described with radiation and combined surgical resection in comparison to resection only [17]. However, these results of radiation therapy can only be achieved due to a higher complication rate [24]. Other studies show a tumor progress after radiation therapy [25] and a high local recurrence rate [26].
Due to the germline mutations and chromosomal aberrations of the APC alleles Bright-Thomas et al. performed a pre-clinical study of gene transfer for the treatment of desmoid disease in FAP [27]. Despite the success of transgene expression, further work is needed in animal models of desmoid disease to assess the clinical effects of gene therapy.
Therefore, the most effective treatment of accessible and smaller desmoid tumors is still the resection with negative margins, although it may not prevent local recurrence [4]. However, massive mesenteric lesions often occur in FAP patients after colectomy [5] and non surgical treatment has variable and unpredictable objective efficacy [10, 21, 28, 29]. Middleton et al. reported on successful short-term surgery in four cases of large intra-abdominal tumors in which non-surgical treatment was inefficient [28]. In conclusion, there remains a need for a wider range of therapeutic options, especially in the management of these massive tumors.
Surgery always aims at radical tumor resection with free margins, which, depending on localisation of surgery, may leave major soft tissue defects behind [28, 30, 31]. Although abdominal wall integrity after full-thickness surgery can be restored with direct sutures [4, 32], reconstruction with synthetic materials is a common technique in major abdominal wall defects [33]. Albeit in our study the small tumor resection with tumor free margins and reconstruction of the abdominal wall was performed with a Bard Composix-Mesh® (figure 5), recent literature data recommend distant or free muscle flaps for greater abdominal wall defect coverage that is not accessible to local flaps [30, 32]. Additionally, prosthetic material is more susceptible to bacterial infection and other complications [34, 35], although new developed material showed encouraging experimental results [36].
In conclusion, the treatment of desmoid tumors remains enigmatic. Non-surgical treatment resulted in diverse and unpredictable outcome and is considered to be an opportunity in patients with unresectable lesions or for adjuvant therapy. Radical resection with clear margins remains the principal determinant of outcome with the risk of local recurrence.

Competing interests

None declared.

Authors' contributions

MO participated in the preparation of the manuscript, literature search and drafted the manuscript.
PD was responsible for the operations, follow-up of the patients and data preparation and conceived of the study.
HPF carried out the tissue preparation, (immuno)histology and edited the manuscript for its scientific content.
HJT accomplished and analysed the CT scans and MRT and approved the final version of the manuscript.
AH participated in its design and coordination.
All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Fletcher CDM: Myofibroblastic tumours: an update. Verh Dtsch Ges Path. 1998, 82: 75-82. Fletcher CDM: Myofibroblastic tumours: an update. Verh Dtsch Ges Path. 1998, 82: 75-82.
2.
Zurück zum Zitat Kiel KD, Suit HD: Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer. 1984, 54: 2051-2055.CrossRefPubMed Kiel KD, Suit HD: Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer. 1984, 54: 2051-2055.CrossRefPubMed
3.
Zurück zum Zitat Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF: The enigma of desmoid tumors. Ann Surg. 1999, 229: 866-872. 10.1097/00000658-199906000-00014.PubMedCentralCrossRefPubMed Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF: The enigma of desmoid tumors. Ann Surg. 1999, 229: 866-872. 10.1097/00000658-199906000-00014.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF: Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999, 86: 2045-2052. 10.1002/(SICI)1097-0142(19991115)86:10<2045::AID-CNCR23>3.3.CO;2-6.CrossRefPubMed Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF: Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999, 86: 2045-2052. 10.1002/(SICI)1097-0142(19991115)86:10<2045::AID-CNCR23>3.3.CO;2-6.CrossRefPubMed
5.
Zurück zum Zitat Nugent KP, Spigelman AD, Phillips RK: Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum. 1993, 36: 1059-1062.CrossRefPubMed Nugent KP, Spigelman AD, Phillips RK: Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum. 1993, 36: 1059-1062.CrossRefPubMed
6.
Zurück zum Zitat Dangel A, Meloni AM, Lynch HT, Sandberg AA: Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. Cancer Genet Cytogenet. 1994, 78: 94-98. 10.1016/0165-4608(94)90053-1.CrossRefPubMed Dangel A, Meloni AM, Lynch HT, Sandberg AA: Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. Cancer Genet Cytogenet. 1994, 78: 94-98. 10.1016/0165-4608(94)90053-1.CrossRefPubMed
7.
Zurück zum Zitat Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, Muraoka M, Mori T, Konishi F, Iwama T: Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 1993, 53: 5079-5082.PubMed Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, Muraoka M, Mori T, Konishi F, Iwama T: Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 1993, 53: 5079-5082.PubMed
8.
Zurück zum Zitat Palmirotta R, Curia MC, Esposito DL, Valanzano R, Messerini L, Ficari F, Brandi ML, Tonelli F, Mariani-Costantini R, Battista P: Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors. Hum Mol Genet. 1995, 4: 1979-1981.CrossRefPubMed Palmirotta R, Curia MC, Esposito DL, Valanzano R, Messerini L, Ficari F, Brandi ML, Tonelli F, Mariani-Costantini R, Battista P: Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors. Hum Mol Genet. 1995, 4: 1979-1981.CrossRefPubMed
9.
Zurück zum Zitat de Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willen H: Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology. Mod Pathol. 2000, 13: 1080-1085.CrossRefPubMed de Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willen H: Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology. Mod Pathol. 2000, 13: 1080-1085.CrossRefPubMed
10.
Zurück zum Zitat Lynch HT, Fitzgibbons R, Jr: Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol. 1996, 91: 2598-2601.PubMed Lynch HT, Fitzgibbons R, Jr: Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol. 1996, 91: 2598-2601.PubMed
11.
Zurück zum Zitat Hasegawa SL, Fletcher CDM: Fibromatosis in the adult. Adv Pathol. 1996, 9: 259-275. Hasegawa SL, Fletcher CDM: Fibromatosis in the adult. Adv Pathol. 1996, 9: 259-275.
12.
Zurück zum Zitat Gacouin A, Desrues B, Lecoz A, Quinquenel ML, Ramee MP, Delaval P: [Desmoid tumor of the thoracic wall]. Rev Mal Respir. 1993, 10: 554-556.PubMed Gacouin A, Desrues B, Lecoz A, Quinquenel ML, Ramee MP, Delaval P: [Desmoid tumor of the thoracic wall]. Rev Mal Respir. 1993, 10: 554-556.PubMed
13.
Zurück zum Zitat Budzynski A, Wysocki A: [Retroperitoneal desmoid tumor]. Przegl Lek. 1996, 53: 506-507.PubMed Budzynski A, Wysocki A: [Retroperitoneal desmoid tumor]. Przegl Lek. 1996, 53: 506-507.PubMed
14.
Zurück zum Zitat Soravia C, Berk T, McLeod RS, Cohen Z: Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 2000, 43: 363-369.CrossRefPubMed Soravia C, Berk T, McLeod RS, Cohen Z: Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 2000, 43: 363-369.CrossRefPubMed
15.
Zurück zum Zitat De Cian F, Delay E, Rudigoz RC, Ranchere D, Rivoire M: Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management. Gynecol Oncol. 1999, 75: 145-148. 10.1006/gyno.1999.5539.CrossRefPubMed De Cian F, Delay E, Rudigoz RC, Ranchere D, Rivoire M: Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management. Gynecol Oncol. 1999, 75: 145-148. 10.1006/gyno.1999.5539.CrossRefPubMed
16.
Zurück zum Zitat Gansar GF, Markowitz IP, Cerise EJ: Thirty years of experience with desmoid tumors at Charity Hospital. Am Surg. 1987, 53: 318-319.PubMed Gansar GF, Markowitz IP, Cerise EJ: Thirty years of experience with desmoid tumors at Charity Hospital. Am Surg. 1987, 53: 318-319.PubMed
17.
Zurück zum Zitat Nuyttens JJ, Rust PF, Thomas CR, Jr, Turrisi AT,III: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer. 2000, 88: 1517-1523. 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.3.CO;2-0.CrossRefPubMed Nuyttens JJ, Rust PF, Thomas CR, Jr, Turrisi AT,III: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer. 2000, 88: 1517-1523. 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.3.CO;2-0.CrossRefPubMed
18.
Zurück zum Zitat Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G: Imaging of intra- and extraabdominal desmoid tumors. Radiographics. 1991, 11: 959-968.CrossRefPubMed Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G: Imaging of intra- and extraabdominal desmoid tumors. Radiographics. 1991, 11: 959-968.CrossRefPubMed
19.
Zurück zum Zitat Mentzel T, Katenkamp D: [Myofibroblastic tumors. Brief review of clinical aspects, diagnosis and differential diagnosis]. Pathologe. 1998, 19: 176-186. 10.1007/s002920050271.CrossRefPubMed Mentzel T, Katenkamp D: [Myofibroblastic tumors. Brief review of clinical aspects, diagnosis and differential diagnosis]. Pathologe. 1998, 19: 176-186. 10.1007/s002920050271.CrossRefPubMed
20.
Zurück zum Zitat Shields CJ, Winter DC, Kirwan WO, Redmond HP: Desmoid tumours. Eur J Surg Oncol. 2001, 27: 701-706. 10.1053/ejso.2001.1169.CrossRefPubMed Shields CJ, Winter DC, Kirwan WO, Redmond HP: Desmoid tumours. Eur J Surg Oncol. 2001, 27: 701-706. 10.1053/ejso.2001.1169.CrossRefPubMed
21.
Zurück zum Zitat Waddell WR, Kirsch WM: Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg. 1991, 161: 416-421.CrossRefPubMed Waddell WR, Kirsch WM: Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg. 1991, 161: 416-421.CrossRefPubMed
22.
23.
Zurück zum Zitat Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors. Cancer. 1993, 72: 3244-3247.CrossRefPubMed Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors. Cancer. 1993, 72: 3244-3247.CrossRefPubMed
24.
Zurück zum Zitat Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT: The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 1997, 39: 659-665. 10.1016/S0360-3016(97)00334-9.CrossRefPubMed Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT: The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 1997, 39: 659-665. 10.1016/S0360-3016(97)00334-9.CrossRefPubMed
25.
Zurück zum Zitat Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC: Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984, 66: 1369-1374.PubMed Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC: Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984, 66: 1369-1374.PubMed
26.
Zurück zum Zitat Pritchard DJ, Nascimento AG, Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1996, 78: 848-854.PubMed Pritchard DJ, Nascimento AG, Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1996, 78: 848-854.PubMed
27.
Zurück zum Zitat Bright-Thomas RM, Agrawal A, Hargest R: Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg. 2002, 89: 1563-1569. 10.1046/j.1365-2168.2002.02277.x.CrossRefPubMed Bright-Thomas RM, Agrawal A, Hargest R: Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg. 2002, 89: 1563-1569. 10.1046/j.1365-2168.2002.02277.x.CrossRefPubMed
28.
Zurück zum Zitat Middleton SB, Phillips RK: Surgery for large intra-abdominal desmoid tumors: report of four cases. Dis Colon Rectum. 2000, 43: 1759-1762.CrossRefPubMed Middleton SB, Phillips RK: Surgery for large intra-abdominal desmoid tumors: report of four cases. Dis Colon Rectum. 2000, 43: 1759-1762.CrossRefPubMed
29.
Zurück zum Zitat Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumors. Cancer. 2003, 97: 1134-1135. 10.1002/cncr.11189.CrossRefPubMed Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumors. Cancer. 2003, 97: 1134-1135. 10.1002/cncr.11189.CrossRefPubMed
30.
Zurück zum Zitat Brenner P, Rammelt S: Abdominal wall and foot reconstruction after extensive desmoid tumor resection with free tissue transfer. Langenbecks Arch Surg. 2002, 386: 592-597. 10.1007/s00423-002-0277-y.CrossRefPubMed Brenner P, Rammelt S: Abdominal wall and foot reconstruction after extensive desmoid tumor resection with free tissue transfer. Langenbecks Arch Surg. 2002, 386: 592-597. 10.1007/s00423-002-0277-y.CrossRefPubMed
31.
Zurück zum Zitat Sutton RJ, Thomas JM: Desmoid tumours of the anterior abdominal wall. Eur J Surg Oncol. 1999, 25: 398-400. 10.1053/ejso.1999.0664.CrossRefPubMed Sutton RJ, Thomas JM: Desmoid tumours of the anterior abdominal wall. Eur J Surg Oncol. 1999, 25: 398-400. 10.1053/ejso.1999.0664.CrossRefPubMed
32.
Zurück zum Zitat Rohrich RJ, Lowe JB, Hackney FL, Bowman JL, Hobar PC: An algorithm for abdominal wall reconstruction. Plast Reconstr Surg. 2000, 105: 202-216.CrossRefPubMed Rohrich RJ, Lowe JB, Hackney FL, Bowman JL, Hobar PC: An algorithm for abdominal wall reconstruction. Plast Reconstr Surg. 2000, 105: 202-216.CrossRefPubMed
33.
Zurück zum Zitat Bauer JJ, Salky BA, Gelernt IM, Kreel I: Repair of large abdominal wall defects with expanded polytetrafluoroethylene (PTFE). Ann Surg. 1987, 206: 765-769.PubMedCentralCrossRefPubMed Bauer JJ, Salky BA, Gelernt IM, Kreel I: Repair of large abdominal wall defects with expanded polytetrafluoroethylene (PTFE). Ann Surg. 1987, 206: 765-769.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Disa JJ, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg. 1996, 97: 801-806.CrossRefPubMed Disa JJ, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg. 1996, 97: 801-806.CrossRefPubMed
35.
Zurück zum Zitat Leber GE, Garb JL, Alexander AI, Reed WP: Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg. 1998, 133: 378-382. 10.1001/archsurg.133.4.378.CrossRefPubMed Leber GE, Garb JL, Alexander AI, Reed WP: Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg. 1998, 133: 378-382. 10.1001/archsurg.133.4.378.CrossRefPubMed
36.
Zurück zum Zitat Disa JJ, Chiaramonte MF, Girotto JA, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg. 2001, 108: 2086-2087. 10.1097/00006534-200112000-00040.CrossRefPubMed Disa JJ, Chiaramonte MF, Girotto JA, Klein MH, Goldberg NH: Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg. 2001, 108: 2086-2087. 10.1097/00006534-200112000-00040.CrossRefPubMed
Metadaten
Titel
Desmoid tumors of the abdominal wall: A case report
verfasst von
Marcus Overhaus
Pan Decker
Hans Peter Fischer
Hans Jochen Textor
Andreas Hirner
Publikationsdatum
01.12.2003
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2003
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-1-11

Weitere Artikel der Ausgabe 1/2003

World Journal of Surgical Oncology 1/2003 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.